• Share
  • Add this to...
  • Favorites
  • Del.icio.us
  • Digg
  • Facebook
  • Google Bookmarks
  • Yahoo MyWeb
• 
• 
• 
• 

Covered Countermeasures

The Countermeasures Injury Compensation Program (CICP) provides compensation to certain individuals who suffer serious adverse events from covered diagnostic devices, medications, or therapies used to identify, prevent, or treat certain conditions.

Countermeasures eligible for compensation under the CICP include:

Countermeasures concerning pandemic influenza A and influenza A with pandemic potential (such as the 2009 H1N1 influenza A

• Certain flu vaccines

Monovalent influenza vaccines including both the injectable and intranasal spray formulations used to prevent pandemic influenza A and influenza A with pandemic potential (such as the 2009 H1N1 influenza A)

For seasonal flu vaccine injuries, please see the VICP.

• Antiviral medications

Tamiflu or Relenza when used for treatment or prevention of pandemic or potentially pandemic influenza A strains; and, peramivir (only for the treatment of the pandemic H1N1 influenza)

• Personal Respiratory Protection Devices such as N-95 filter face masks or surgical type masks when used for protection against pandemic influenza A and influenza A with pandemic potential

• Personal Respiratory Support Devices such as mechanical ventilators

Any vaccine, antiviral, antimicrobial, antibiotic, other drug, or diagnostic device used to identify, prevent, or treat

• Smallpox or other orthopoxviruses
• Anthrax
• Botulism (botulinum toxin)
• Acute Radiation Syndrome and sequella

***Please note that individual eligibility is determined on a case-by-case basis dependent on substantial proof that the vaccine or countermeasure caused the injury.***